[go: up one dir, main page]

PE46599A1 - METHOD OF USE OF NEUROTROPIC CARBAMATES AND UREAS - Google Patents

METHOD OF USE OF NEUROTROPIC CARBAMATES AND UREAS

Info

Publication number
PE46599A1
PE46599A1 PE1998000117A PE00011798A PE46599A1 PE 46599 A1 PE46599 A1 PE 46599A1 PE 1998000117 A PE1998000117 A PE 1998000117A PE 00011798 A PE00011798 A PE 00011798A PE 46599 A1 PE46599 A1 PE 46599A1
Authority
PE
Peru
Prior art keywords
alkyl
alkyll
group
ch2ar
alkynyl
Prior art date
Application number
PE1998000117A
Other languages
Spanish (es)
Inventor
Gregory S Hamilton
Joseph P Steiner
Jia-He Li
Original Assignee
Guilford Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharm Inc filed Critical Guilford Pharm Inc
Publication of PE46599A1 publication Critical patent/PE46599A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

METODO PARA EFECTIVIZAR UNA ACTIVIDAD NEURONAL EN UN ANIMAL, QUE CONSISTE: ADMINISTRAR AL ANIMAL UNA CANTIDAD NEUROTROPICAMENTE EFECTIVA DEL COMPUESTO DE FORMULA I, O UNA SAL, DONDE A ES CH2, O, NH, o N-ALQUILO C1-C4, B Y D SON, INDEPENDIENTEMENTE, Ar, H, ALQUILO C1-C6, ALQUENILO O ALQUINILO C3-C6 CON SUSTITUCION DE CICLOALQUILO C5-C7 o Ar; LOS CH2 DE LAS CADENAS DE ALQUILO SON REEMPLAZADOS POR UN HETEROATOMO: O, S, SO, SO2, Y NR, DONDE R PUEDE SER: H, ALQUILO C1-C4, ALQUENILO O ALQUINILO C3-C4, J PUEDE SER: H, ALQUILO C1-C6, ALQUENILO C3-C6 Y -CH2Ar, K PUEDE SER ALQUILO C1-C4, -CH2Ar Y CICLOHEXILMETILO, Z ES O o S, Y ES O o N, CUANDO Y ES O, ENTONCES R1 ES UN PAR SOLITARIO Y R2 PUEDE SER Ar, ALQUILO C1-C6 Y ALQUENILO O ALQUINILO C3-C6, Y CUANDO Y ES N, R1 Y R2 SE SELECCIONAN INDEPENDIENTEMENTE DEL GRUPO DE: Ar, ALQUILO C1-C6, ALQUENILO O ALQUINILO C3-C6 o R1 Y R2 SE TOMAN JUNTOS PARA FORMAR UN ANILLO HETEROCICLICO DE 5 A 6 MIEMBROS SELECCIONADOS DEL GRUPO DE PIRROLIDINA, IMIDAZOLIDINA, PIRAZOLIDINA, PIPERIDINA Y PIPERACINA, R3 Y R4 SE SELECCIONAN INDEPENDIENTEMENTE DEL GRUPO DE ALQUILO C1-C6, ALQUENILO C3-C6, H Y BENCILO o R3 Y R4 PUEDEN TOMARSE JUNTOS PARA FORMAR UN ANILLO HETEROCICLICO DE 5 A 6 MIEMBROS, X PUEDE SER: 4-METOXIFENILO, PIRACILO, QUINOLILO, PIRIMIDINILO, COMPUESTOS DE ISOXAZOILO, PIRIDILO, TIAZOLILO O TIENILOMETHOD FOR PERFORMING A NEURONAL ACTIVITY IN AN ANIMAL, WHICH CONSISTS: ADMINISTERING THE ANIMAL A NEUROTROPICALLY EFFECTIVE AMOUNT OF THE COMPOUND OF FORMULA I, OR A SALT, WHERE A IS CH2, O, NH, or N-ALKYL C1-C4, BYD SON, INDEPENDENTLY, Ar, H, C1-C6 ALKYL, C3-C6 ALKYL OR ALKYNYL WITH CYCLOALKYL C5-C7 OR Ar SUBSTITUTION; THE CH2 OF THE ALKYL CHAINS ARE REPLACED BY A HETEROATOM: O, S, SO, SO2, AND NR, WHERE R MAY BE: H, C1-C4 ALKYL, ALKYLL OR C3-C4 ALKYLL, J MAY BE: H, ALKYL C1-C6, ALKYLL C3-C6 AND -CH2Ar, K MAY BE ALKYL C1-C4, -CH2Ar AND CYCLOHEXILMETILO, Z IS O or S, Y IS O or N, WHEN Y IS O, THEN R1 IS A SOLITARY PAIR AND R2 MAY BE Ar, C1-C6 ALKYL AND ALKYNYL OR C3-C6 ALKYLL, AND WHEN Y IS N, R1 AND R2 ARE SELECTED INDEPENDENTLY FROM THE GROUP OF: Ar, C1-C6 ALKYL, OR C3-C6 ALKYLYL OR R1 AND R2 SE TOGETHER TOGETHER TO FORM A HETERO-CYCLIC RING OF 5 TO 6 SELECTED MEMBERS FROM THE GROUP OF PIRROLIDINE, IMIDAZOLIDINE, PIRAZOLIDINE, PIPERIDINE AND PIPERACINE, R3 AND R4 SELECTED FROM THE ALKYL GROUP C1-C6-CYO-C6 R4 MAY BE TAKEN TOGETHER TO FORM A HETERO CYCLIC RING OF 5 TO 6 MEMBERS, X MAY BE: 4-METOXYPHENYL, PIRACIL, QUINOLYL, PYRIMIDINYL, COMPOUNDS OF ISOXAZOIL, PIRIDYL, THIAZOLYL OR THEN ILO

PE1998000117A 1997-02-27 1998-02-19 METHOD OF USE OF NEUROTROPIC CARBAMATES AND UREAS PE46599A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80564697A 1997-02-27 1997-02-27

Publications (1)

Publication Number Publication Date
PE46599A1 true PE46599A1 (en) 1999-05-12

Family

ID=25192108

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000117A PE46599A1 (en) 1997-02-27 1998-02-19 METHOD OF USE OF NEUROTROPIC CARBAMATES AND UREAS

Country Status (9)

Country Link
EP (1) EP1001762A4 (en)
JP (1) JP2001513772A (en)
AR (1) AR011869A1 (en)
AU (1) AU6181698A (en)
CA (1) CA2281096A1 (en)
PA (1) PA8447901A1 (en)
PE (1) PE46599A1 (en)
WO (1) WO1998037882A1 (en)
ZA (1) ZA98825B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218424B1 (en) * 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
US6242468B1 (en) * 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
OA11581A (en) 1998-07-17 2004-07-23 Agouron Pharma Compounds, compositions, and methods for stimulating neuronal growth and elongation.
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US7338976B1 (en) * 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6376517B1 (en) * 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
RU2241709C2 (en) * 1999-07-09 2004-12-10 Орто-Макнейл Фармасьютикал, Инк. Derivatives of nitrogen-containing heterocyclic compounds and method for treatment of disorders with neurons injury
AU5483500A (en) 1999-07-09 2001-01-30 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
WO2001004090A2 (en) * 1999-07-09 2001-01-18 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
JP2003508512A (en) * 1999-09-08 2003-03-04 ギルフォード ファーマシュウティカルズ インコーポレイテッド Non-peptidic cyclophilin binding compounds and their uses
CO5261615A1 (en) 1999-12-01 2003-03-31 Agouron Pharma COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND ELONGATION OF NEURONS
MXPA03004821A (en) * 2000-11-28 2004-03-26 Guilford Pharm Inc Bisubstituted carbocyclic cyclophilin binding compounds and theirus.
MXPA03006666A (en) * 2001-01-25 2004-05-31 Guilford Pharm Inc Trisubstituted carbocyclic cyclophilin binding compounds and their use.
EP1402888A1 (en) * 2002-09-18 2004-03-31 Jerini AG The use of substituted carbocyclic compounds as rotamases inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620971A (en) * 1991-05-09 1997-04-15 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US6037370A (en) * 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds

Also Published As

Publication number Publication date
PA8447901A1 (en) 2000-05-24
EP1001762A4 (en) 2002-05-08
AU6181698A (en) 1998-09-18
ZA98825B (en) 1998-10-19
EP1001762A1 (en) 2000-05-24
JP2001513772A (en) 2001-09-04
AR011869A1 (en) 2000-09-13
CA2281096A1 (en) 1998-09-03
WO1998037882A1 (en) 1998-09-03

Similar Documents

Publication Publication Date Title
PE46599A1 (en) METHOD OF USE OF NEUROTROPIC CARBAMATES AND UREAS
DE3876211D1 (en) BENZOTHIADIAZOLES AND THEIR USE IN METHODS AND AGENTS AGAINST PLANT DISEASES.
ES8103753A1 (en) PROCEDURE FOR THE PREPARATION OF ACIDES 3-CEFEM-4-CARBO-XILICOS SUBSTITUTED IN POSITION 7
ATE203234T1 (en) META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINOBENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS
EA200100487A1 (en) DERIVATIVES OF 2-AMINOTHIAZOLE, METHOD FOR THEIR RECOVERY AND USE OF THE SPECIFIED SUBSTANCES AS ANTIFE-CHEMICAL AGENTS
CO5590957A2 (en) AMINO-1,3,5-TRIAZINES REPLACED IN N WITH CHIRAL BICYCLE RADICALS, PROCEDURE FOR PREPARATION, COMPOSITIONS OF THE SAME AND ITS USE AS HERBICIDES AND REGULATORS OF GROWTH OF PLANTS
NZ334186A (en) Neurotrophic heterocyclic esters and amides with an affinity to FKBP-type immunophilins
DK0624584T3 (en) Piperazine derivatives useful as calmodulin inhibitors
PE46899A1 (en) N-PHENYL-SULFONAMIDE DERIVATIVES
YU36693A (en) Erythromycin derivatives
ES8800682A1 (en) A PROCEDURE FOR THE PREPARATION OF NEW (4-PIPERIDINILMETIL AND HETEROPURINAS)
ES2054826T3 (en) PEPTIDES WITH COLAGENASA INHIBITING ACTIVITY.
ES2053508T3 (en) COMPOUNDS OF 3-PIRROLIDINYL-THIO-1-AZABICICLO (3.2.0) HEPT-2-ENO-2-CARBOXILICOS.
PT92153A (en) PROCESS FOR THE PREPARATION OF 1,4-DIAZEPINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MX165512B (en) CARBAMATE ADDITIVE FOR LUBRICATING COMPOSITION
DK0559533T3 (en) Process for the preparation of beta-lactam derivative and its synthetic intermediate
ATE102831T1 (en) METHODS TO PREVENT OR LIMIT REPERFUSION INJURY.
ES8702341A1 (en) A PROCEDURE FOR THE PRODUCTION OF A N-ACILAMINOACIDIA DIAMEDIA DERIVATIVE
MX9207603A (en) DERIVATIVES OF ISOXAZOLCARBOXILIC ACIDS AND PROCEDURE FOR THEIR OBTAINING.
ES2134314T3 (en) THIOXANTHENONE ANTI-TUMOR AGENTS.
PE58099A1 (en) UREAS AND CARBAMATES LINKED IN N OF HETERO CYCLIC ESTERS
KR910000133A (en) Amine
PE62099A1 (en) N-LINKED SULPHONAMIDES OF HETERO CYCLIC THIOESTERS
ES2057415T3 (en) BICYCLE DERIVATIVES.
BG60248B2 (en) Process for the preparation of phenoxyethylamine derivatives

Legal Events

Date Code Title Description
FC Refusal